You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

Grants awarded in Israel-Mass. pact

The first round of grants, totaling at least $1.3 million, under the Massachusetts-Israel Innovation Partnership was awarded Tuesday at the BIO International Convention in Boston.

MIIP is a collaboration between Israel and Massachusetts to encourage and support innovation and entrepreneurship in life sciences, clean energy, and technology. Governor Deval Patrick and Israeli Chief Scientist Avi Hasson jointly named the grant recipients.

Continue reading below

The program was unveiled at last year’s Biotechnology Industry Organization convention in Washington, D.C., and the first joint solicitation for proposals was launched in September by Israel, the Massachusetts Life Sciences Center, the Massachusetts Technology Collaborative, and the Massachusetts Clean Energy Center.

The funding agencies approved four research and development collaborations. At least $1.3 million is being awarded to four research and development collaborations between Massachusetts and Israeli companies that have been jointly approved by the funding agencies on both sides. .

The four winning projects are:

Continue reading it below

 SBH Sciences of Natick and Improdia of Israel. They will work together to develop and manufacture a medical prognostic kit.

 Automated Medical Instruments of Needham and STI Lasers of Israel. They will develop radio-frequency technology to treat heart arryhtmia.

 Lantheus of North Billerica and Check-Cap of Israel. They will develop a novel 3-D imaging capsule that can be used to screen for polyps and lesions associated with colorectal cancer.

 FloDesign Sonics of Wilbraham and Transbiodiesel of Israel, the clean energy award winners. Their joint project will use FloDesign’s technology to separate oil that can be used to create fuel from Transbiodiesel’s oil-generating algae.

Massachusetts is the first US state to establish a significant industrial R&D program with the State of Israel.

Boosting the state’s international partnerships, Massachusetts officials also unveiled a multinational research study on throat cancer and a joint US-EU connected health conference set for Boston in October.

State Senate president Therese Murray, a Democrat from Plymouth, made the announcement.

The collaboration, which will be led by Dr. Ramon Franco of the Massachusetts Eye and Ear Infirmary, will include doctors and scientists from Finland, Northern Ireland, and Spain.

Robert Weisman of the Globe staff contributed to this report. D.C. Denison can be reached at denison@globe.com.
Loading comments...
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.